Health Care
(E60)
IRS Verified
DX Registered
990 on File
COLORECTAL CANCER ALLIANCE INC
Financial strength (30%)
62/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
We exist to end colorectal cancer in our lifetime. As the largest nonprofit dedicated to this disease, we empower a nation of allies who are overcoming colorectal cancer in their lives and communities.
Financial Overview — FY 2025
$17.4M
Total Revenue
$22.8M
Total Expenses
$8.5M
Net Assets
80
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
80.7%
Fundraising Efficiency
347.3%
Operating Reserve
4.47x
Liability-to-Asset
42.0%
Revenue Diversification
99.0%
Executive Compensation
$1.8M
Compared with Peers
FY 2025
Compared with 1,090 similar organizations
(United States, Health Care, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
80.7% | 85.0% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.3% | 14.0% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
10.0% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
347.3% | 299.7% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
4.5 mo | 7.3 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
42.0% | 31.3% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.0% | 89.7% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-16.1% | 7.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
28.1% | 6.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-30.8% | 2.5% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $17.4M | $22.8M | $8.5M | 80.7% | 80 |
| 2024 | $20.7M | $17.8M | $14.2M | 76.9% | 69 |
| 2023 | $20.7M | $16.9M | $11.2M | 64.6% | 75 |
| 2022 | $11.6M | $13.8M | $7.2M | 68.9% | 73 |
| 2021 | $28.5M | $11.6M | N/A | — | 56 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.